🇺🇸 FDA
Patent

US 10434134

Peptide treatment for inflammation and fibrosis

granted A61KA61K38/00A61K38/07

Quick answer

US patent 10434134 (Peptide treatment for inflammation and fibrosis) held by The Regents of the University of California expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61K38/07, A61K47/10, A61K47/60